Results 241 to 250 of about 62,013 (267)

Infliximab

Reactions Weekly, 2018
openaire   +2 more sources

Infliximab

Reactions Weekly, 2010
openaire   +1 more source

Infliximab

Reactions Weekly, 2007
openaire   +2 more sources

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Lancet, The, 2002
Stephen B Hanauer
exaly  

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

Lancet, The, 2017
Espen A Haavardsholm, Knut E A Lundin, Jørgen Jahnsen   +2 more
exaly  

Infliximab

Reactions Weekly
  +4 more sources

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

Lancet, The, 2012
David Laharie, Matthieu Allez, Maria Nachury   +2 more
exaly  

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

Lancet, The, 2002
Juergen Braun
exaly  

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial

Lancet, The, 2005
Kristian Reich, Christopher Em Griffiths, Christopher E M Griffiths   +2 more
exaly  

Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial

Gut, 2014
Zhenhua Xu, Séverine Vermeire
exaly